PDCD1 and neoplasm: Although the exact mechanism of TIGIT and PD-1 co-expression has not been exactly identified in tumors, the currently available evidence indicates that TIGIT and PD-1 can both increase arginase-1 activity, which can ultimately lead to T cells anergy and the development of immunosuppressive tumor microenvironment.